Click to copy
Click to copy

Kindred Bio: 2Q Earnings Snapshot

August 1, 2019

BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Thursday reported a loss of $14.3 million in its second quarter.

The Burlingame, California-based company said it had a loss of 37 cents per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share.

The biopharmaceutical company posted revenue of $1.2 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $2 million.

Kindred Bio shares have declined 36% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $6.96, a decrease of 49% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KIN at https://www.zacks.com/ap/KIN

All contents © copyright 2019 The Associated Press. All rights reserved.